Jump Financial LLC Buys Shares of 15,300 Surgery Partners, Inc. $SGRY

Jump Financial LLC acquired a new position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 15,300 shares of the company's stock, valued at approximately $363,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Janus Henderson Group PLC lifted its position in Surgery Partners by 110.2% in the fourth quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock worth $244,616,000 after purchasing an additional 6,057,477 shares during the period. Wellington Management Group LLP lifted its position in Surgery Partners by 19.7% in the first quarter. Wellington Management Group LLP now owns 7,091,756 shares of the company's stock worth $168,429,000 after purchasing an additional 1,165,667 shares during the period. King Street Capital Management L.P. lifted its position in Surgery Partners by 93.1% in the fourth quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock worth $59,276,000 after purchasing an additional 1,350,000 shares during the period. Point72 Asset Management L.P. lifted its position in Surgery Partners by 224.7% in the fourth quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock worth $36,975,000 after purchasing an additional 1,208,639 shares during the period. Finally, Silvercrest Asset Management Group LLC lifted its position in Surgery Partners by 44.9% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 998,505 shares of the company's stock worth $21,138,000 after purchasing an additional 309,481 shares during the period.

Insider Activity at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of the stock in a transaction on Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director owned 45,173 shares in the company, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 2.70% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on SGRY shares. Bank of America started coverage on Surgery Partners in a research report on Monday, July 28th. They issued a "buy" rating and a $28.00 target price for the company. Barclays cut their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 27th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY traded up $0.15 on Friday, reaching $22.51. 1,035,308 shares of the company traded hands, compared to its average volume of 1,316,687. Surgery Partners, Inc. has a fifty-two week low of $18.87 and a fifty-two week high of $33.90. The company's 50 day moving average is $22.48 and its 200-day moving average is $22.68. The stock has a market capitalization of $2.89 billion, a PE ratio of -15.74 and a beta of 1.76. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. During the same quarter in the prior year, the firm earned $0.21 EPS. The company's quarterly revenue was up 8.4% compared to the same quarter last year. As a group, analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.